Skip to main content
. 2009 Jul 27;53(10):4292–4297. doi: 10.1128/AAC.01664-08

TABLE 3.

Effect of ciprofloxacin on viable organisms in kidneys of mice infected with the four E. coli strains used in the study

E. coli strain (plasmid) Results (log CFU/g of kidney ± SD [no. of mice]) for mice treated with:
Start-of-treatment control End-of-treatment control Ciprofloxacin
CFT703-RR 5.0 ± 0.5 (15) 5.0 ± 1.1 (15) 3.6 ± 0.8 (15)a
CFT703-RR Tc (pQnrA1) 3.4 ± 0.9 (15) 3.0 ± 0.8 (15) 2.7 ± 0.6 (16)b
CFT703-RR Tc (pQnrS1) 4.6 ± 1.0 (15) 4.5 ± 1.1 (15) 4.2 ± 0.7 (16)b
CFT703-RR-gyrA 3.9 ± 1.4 (15) 4.0 ± 1.3 (15) 4.1 ± 1.4 (16)b
a

P was 0.001 compared with the end-of-treatment control group.

b

P was >0.2 compared with the end-of-treatment control group.

HHS Vulnerability Disclosure